|
Gilbertsville,
PA 19525 Fax |
|
CURRICULUM
VITAE Name:
George Poste Present Appointment: Chief Executive Officer Health
Technology Networks P.O.
Box 647 Gilbertsville,
PA 19525 USA (Telephone: 610-705-0828) (FAX: 610-705-0810) (E.mail: gposte@healthtechnetwork.com Current Academic Affiliations: Distinguished
Visiting Fellow, Hoover
Institution Stanford
University Research
Professor, Department of Cell Biology The
University of Texas, M.D. Anderson Cancer Center Houston,
TX 77030 William
Pitt Fellow, Pembroke College, University
of Cambridge, England Place and Date of Birth: Polegate,
Sussex, England, April 30, 1944 Family: Married
with three children Citizenship: U.S. Education, Qualifications and Honors: 1966 D.V.M. University of Bristol, England
(Veterinary Medicine) (Graduated first in class) 1969 Ph.D. University of Bristol, England (Virology) 1979 M.R.C. Path. Membership, Royal College of Pathologists,
London, England (Board Certification in
Pathology) 1987 D.Sc. University of Bristol, England 1987 F.R.C.V.S. Elected Fellow, Royal College of Veterinary Surgeons, London, England 1989 F.R.C. Path. Elected Fellow, Royal College of Pathologists, London, England 1993 F.R.C.P.
(Hon.) Elected
Fellow, Faculty of Pharmaceutical Medicine, Royal
College of Physicians, London, England 1994 F.R.S.A. Elected
Fellow, Royal Society of Arts, Manufactures and
Commerce, London, England 1995 LL.D.
(Hon.) University
of Bristol, England 1997 F.R.S. Elected
Fellow, The Royal Society, London, England 1998 F.Med.Sci. Elected Fellow, The Academy of Medical Sciences, London, England 1998 LL.D. (Hon.) University of Dundee, Scotland 1999 C.B.E. Commander
of the Order of the British Empire, Honours
List, H.M. Queen 1999 Honorary Fellow University College London 2000 Member Elected Member, Worshipful Company of Apothecaries, London 2004 Member Council on Foreign Relations Previous Appointments: 1997 – 1999 Chief
Science and Technology Officer, SmithKline Beecham, Philadelphia 1991 - 1997 President,
Research and Development, SmithKline Beecham Pharmaceuticals, Philadelphia,
Pennsylvania 1989 - 1991 Executive
Vice President, Research and Development, SmithKline
Beecham Pharmaceuticals, Philadelphia,
Pennsylvania 1988 ‑ l989 President,
Research and Development, Smith
Kline & French Laboratories, Philadelphia, Pennsylvania 1987 ‑ 1988 Vice
President, Worldwide Research and Preclinical Development, Smith Kline &
French Laboratories, Philadelphia, Pennsylvania 1983
‑ 1986 Vice
President, Research and Development, Smith
Kline & French Laboratories, Philadelphia, Pennsylvania 1980 ‑ 1983 Vice
President and Director of Research, Smith
Kline & French Laboratories, Philadelphia, Pennsylvania 1975 ‑ 1980 Principal
Cancer Research Scientist, Department
of Experimental Pathology, Roswell
Park Memorial Institute, Buffalo,
New York and Professor,
Department of Cell and Molecular Biology, State
University of New York at Buffalo 1974 Senior
Lecturer, Department of Virology, Royal
Postgraduate Medical School, University of London, England 1972 ‑ 1974 Associate
Professor of Experimental Pathology, Roswell
Park Memorial Institute, Buffalo, New York (On
official leave of absence from the University of London) 1970 ‑ 1972 Lecturer
in Virology, Royal Postgraduate Medical School, London,
England 1969 ‑ 1970 Research
Fellow, Department of Virology, Royal
Postgraduate Medical School, University of London, England 1966 ‑ 1969 Research
Fellow and Assistant Lecturer, Department
of Bacteriology, University of Bristol, England Executive Board Memberships: 1992 - 1999 Board
Member, SmithKline Beecham (now GlaxoSmithKline) 2000 – 2003 Board
Member, Illumina 2000 – 2003 Board
Member, Maxygen 1997 – 2003 Chairman,
diaDexus 2000 – 2003 Chairman,
Structural GenomiX 2002 – 2003 Board
Member, AdvancePCS 2002 – present Chairman,
Orchid Biosciences 2003 - present Board
Member, Monsanto 2004 – present Board
Member, Exelixis Professional and Civic Duties: Member, Pathology B
Study Section, National Institute of Health (1980‑1983) Member, Scientific
Advisory Panel, Biological Response Modifiers Program, National
Cancer Institute (1980‑1983) Member, Committee du
Direction, Centre Nationale de Recherche Scientifique (CNRS),
Republic of France (1983‑1986) Member, Board of Governors,
National Association for Biomedical Research (1984-1986) Trustee, Gordon Research
Conferences (1985‑l989) Member, UCLA Conferences
Symposium Board (1985-1990) Member, Board of
Directors, The Royal Society of Medicine Foundation, Inc. (1986-1995) Chairman, Research and
Development Section, Pharmaceutical
Manufacturers Association (1987-1989) Member, Board of
Overseers of the School of Veterinary Medicine, University
of Pennsylvania (1987-1992) Trustee, Philadelphia
College of Pharmacy and Science (1987-1993) Member, Executive
Council, International Society for Differentiation (1988-1992) Member, Scientific
Advisory Board, Institute for Scientific Information, Philadelphia
(1988-1992) Member, President's Council,
M.D. Anderson Cancer Center, University
of Texas (1988-1992) Member, Scientific
Committee, Association
of the British Pharmaceutical Industry (ABPI) (1989-1991) Trustee, The Keystone
Center, Keystone, Colorado (1992-1996) Member, Board of
Directors, Alliance for Aging Research (1993-1997) Member, Governor's Task
Force on Economic Development, Commonwealth
of Pennsylvania (1993-1997) Member,
Research-Intensive Industries Task Force, Institute
for the Future, Menlo Park, CA
(1994) Trustee, Life Sciences
Research Foundation (1988-1998) Member, Advisory
Committee on Global R&D, Council on Competitiveness, Washington,
DC (1998) Member, Standing Group
on Health Technology, National Health Service (UK) (1998) Member, National Health
Service Executive Standing Group on Technology Assessment
(1998) Member, Ministerial
Competitiveness Working Party on Innovation, Department
of Trade and Industry (UK)
(1998) Member, Human Genetics
Advisory Commission (UK Government) (1997 – 1999) Member, BP Technology
Advisory Council
(1998-2000) Member, Board of Medical
Governors, World Economic Forum, Davos (1998-2000) Member, Rand Critical
Technologies Task Force on The Hybrid Carbon Silicon Brain (1998-2001) Member, Governing Board,
Beckman Center for Molecular and Genetic Medicine, Stanford
University (1993–2003) Member, Threat Reduction Advisory Committee,
United States Department of Defense (2001-2005) Member, Defense Science Board, United States
Department of Defense (current) Member, Advisory Committee on International
Economic Policy, United States State Department (current) Member, Biological Weapons Working Group,
National Academy of Sciences (current) Member, Board on Global Health, National
Academy of Sciences Institute of Medicine (current) Member, Committee on Advances in Technology
and Next Generation Biowarfare Threats.
Institute of Medicine:
National Research Council, US National Academy of Sciences (current) Member, Board of Trustees; The International
Vaccine Institute, Seoul, Korea (current) Editorial Responsibilities for Professional
Publications: Founder
and Member,
Editorial Board, Cancer and Metastasis Reviews (1985 – 1996) Member, Editorial Board,
Cancer Invasion and Metastasis (1987 – 1995) Member, Editorial Board,
Drug Targeting and Delivery (1987 – 1999) Member, Editorial Board,
Clinical and Experimental Metastasis (1988 – 1995) Member, Editorial Board,
International Journal of Pharmaceutics (1989 – 1999) Member, Editorial Board,
Journal of Drug Targeting (1990 – 1998) Member, Editorial Board,
Advanced Drug Delivery Reviews (1992 – 1999) Member, Editorial Board,
Nature Bio/Technology (current) Member, Editorial Board,
Current Opinion in Biotechnology (current) Member, Editorial Board,
Expert Opinion on Investigational Drugs (current) Member, Senior Advisory
Panel, Current Drugs (current) Member, Editorial Board,
Polymers in Medicine and Biotechnology (current) Member, Editorial Board,
Journal of Commercial Biotechnology (current) Member, Editorial Board,
Pharmacogenomics (current) Member, Editorial Board,
The Journal of Biolaw and Business (current) Member, Editorial Board,
Bioterrorism and Biosecurity (current) Member, Editorial Board,
Expert Opinion on Molecular Diagnostics (current) Investment Community Advisor, Burrill and
Company Advisor, Care Capital,
Princeton Club Memberships Athenaeum, London |
|
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
|
|
|
|